INS and type 2 diabetes mellitus: Despite continuing advances in insulin delivery technology and recombinant insulins, diabetes and its complications still claim the lives of millions of people as a result of ketoacidosis, hypoglycemic coma or chronic cardiovascular, eye, nerve and kidney damage (4).